Navigation Links
Regulus to Present at Future Leaders in the Biotech Industry Conference
Date:3/28/2013

LA JOLLA, Calif., March 28, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Garry E. Menzel , Ph.D., Chief Operating Officer and Executive Vice President, Finance, will present a company overview at the 20th Annual Future Leaders in the Biotech Industry Conference on Friday, April 5, 2013 at 10:30 am EDT.  The conference is being held at the Millennium Broadway Hotel and Conference Center in New York City.

The presentation will be webcast at the time of the presentation and can be accessed on the Investor Relations page of the Company's website at www.regulusrx.com.  A replay of each webcast will be archived on the Company's website following the presentation date.

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad network of academic collaborators and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals and Isis Pharmaceuticals. Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more information, please visit ht
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
2. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
3. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
4. Regulus to Present at Two Upcoming Investor Conferences
5. Regulus Appoints Mark G. Foletta to its Board of Directors
6. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
7. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
8. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
9. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
10. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
11. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 27, 2015  Finesse expands office in ... Finesse Solutions announced the expansion of its operations in ... planned for mid-March and access for customers is expected ... A-563, and located adjacent to the current office, the ... Finesse automation engineering team and allow Finesse to bring on ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the National ... The psychological and physical side effects of pain medications ... painkillers, such as Vicodin and Oxycontin, are safer options ... overdose on prescription painkillers than on heroin and cocaine ... CEO of NSC. "Yet, these medications are marketed as ...
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015 Legislation ... includes a pharmacy provision to help prevent inappropriate prescriptions ... The Protecting the Integrity of Medicare Act (PIMA) ... Subcommittee Chairman Kevin Brady (R-TX) and Ranking ... the prescription drug abuse epidemic and implement the right ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2
... WILMINGTON, Del. , April 30 ... and Drug Administration (FDA) has approved VIMOVO™ ... of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ... gastric ulcers in patients at risk of developing NSAID-associated ...
... The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine ... as its July 2010 "Stock to Study" and Gilead ... for investors, informational and educational use. , ... "The committee chose Teva Pharmaceutical Industries because of the tremendous ...
Cached Medicine Technology:FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 2FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 3FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 4FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 5FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 6FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 7FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 8FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 9BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3
(Date:2/27/2015)... SACRAMENTO, Calif. (PRWEB) February 27, 2015 ... those who are documented to use Medicaid, the ... and families, according to a new study from ... that the greatest predictor of farmworker use of ... emergency care regardless of documentation status, was having ...
(Date:2/27/2015)... 2015 According to court documents, Donna ... June 25, 2013 and underwent a procedure during which ... mouth. Because the duodenoscope allegedly had not been ... “superbug” carbapenem-resistant Enterobacteriaceae (CRE). , A lawsuit ... County on behalf of Ms. Pirolli alleging that Lutheran ...
(Date:2/27/2015)... The winter season is here, and with ... mold grows, it can be harmful to the home and ... consequences of mold growth with the help of Enviro-Test. Enviro-Test, ... on the best ways to prevent mold during the winter ... conditions for mold to thrive. Mold must be removed properly, ...
(Date:2/27/2015)... Mediaplanet today announces the launch of its second ... to bring blood health and cancer awareness to the ... this edition go beyond the concept of these insidious ... research and technological strides needed to develop new solutions ... approximately every 3 minutes one person in the ...
(Date:2/27/2015)... 27, 2015 “ Logical Operations ” ... Tech Report, which takes a look at the latest ... Mallory Sofastaii, a special reporter for NewsWatch and a ... how this company helps companies avoid cyber security threats. ... they’ll probably see cyber security somewhere in the headlines. ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2
... Imaging(R),Inc., a wholly owned subsidiary of Mercury ... announced it has signed a comprehensive marketing ... 2D/3D medical imaging and,diagnostic software. Under the ... for Viatronix,s V3D-Colon(R) Virtual Colonoscopy product in ...
... PT. RICHMOND, Calif., Nov. 24 Transcept Pharmaceuticals,Inc., a ... President & Chief Executive Officer, is scheduled to,present at ... New York,City on Tuesday, December 2, 2008 at 8:00 ... An audio webcast of the presentation will be ...
... Colo., Nov. 24 LABS Inc., one of the ... added,Dr. Carol Pancoska, a leading figure in the field ... Directors. , Dr. ... of immunology for,over thirty years. She has held various ...
... Site in Southeast to Choose SafeTrace Tx(R) , ... Technologies(R), Inc. ("Global Med") (OTC Bulletin Board: GLOB), an international ... Technologies(R) ("Wyndgate") division has licensed SafeTrace Tx transfusion management software ... Louisiana. Terms of the agreement were not disclosed. ...
... Event,s Healthcare IT Summit today announced the winners of ... place last,week in San Diego, explored the challenges and ... enable care and business strategies. , ... merely transaction processing and,distributing information, CXOs and external influencers ...
... VOLC ), a leader in the development, manufacturing and sales of ... disease, said today that it will be participating in the 20th ... , The presentation by Scott Huennekens, ... Standard Time (10:30 a.m., Pacific Standard Time). , ...
Cached Medicine News:Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 2Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 3Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 4Health News:Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference 2Health News:LABS Inc. Adds Dr. Carol Pancoska as Laboratory Director 2Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 2Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 3Health News:Gulf Coast Hospital Chooses Global Med Technologies(R)' Blood System 4Health News:Everything Channel's Vision Events Announces the Winners of the Healthcare IT Innovation(TM) Awards 2Health News:Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: